Here Are the 3 Most Important Numbers in Moderna's Earnings Report

Here Are the 3 Most Important Numbers in Moderna's Earnings Report

Moderna's (NASDAQ: MRNA) transformation from a clinical-stage biotech company to a commercial-stage one has been rapid -- and impressive. Only a year ago, Moderna didn't even have products on the market. Moderna invested four times more in R&D in the first quarter than it did in the same period a year ago.